Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19.
Crit Care Med.
2023 Sep 1;51(9):e184-e185. doi: 10.1097/CCM.0000000000005933. Epub 2023 Aug 17. PubMed PMID:
37589523.
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
JAMA Netw Open.
2023 Jul 3;6(7):e2321715. doi: 10.1001/jamanetworkopen.2023.21715. PubMed PMID:
37405775; PubMed Central PMCID:
PMC10323710.
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther.
2023 Jul;29(7):455.e1-455.e9. doi: 10.1016/j.jtct.2023.03.029. Epub 2023 Apr 2. PubMed PMID:
37015320; PubMed Central PMCID:
PMC10330095.
Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study.
PLoS One.
2023;18(6):e0285748. doi: 10.1371/journal.pone.0285748. eCollection 2023. PubMed PMID:
37379286; PubMed Central PMCID:
PMC10306211.
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
Oncologist.
2023 Jun 2;28(6):e379-e390. doi: 10.1093/oncolo/oyad001. PubMed PMID:
36821637; PubMed Central PMCID:
PMC10243781.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA.
2023 Apr 11;329(14):1183-1196. doi: 10.1001/jama.2023.4480. PubMed PMID:
37039790; PubMed Central PMCID:
PMC10326520.
Author Correction: Therapeutic advances in COVID-19.
Nat Rev Nephrol.
2023 Apr;19(4):273. doi: 10.1038/s41581-023-00686-0. PubMed PMID:
36747084; PubMed Central PMCID:
PMC9901371.
Reply to 'Use of convalescent plasma in the treatment of COVID-19'.
Nat Rev Nephrol.
2023 Apr;19(4):272. doi: 10.1038/s41581-023-00691-3. PubMed PMID:
36806371; PubMed Central PMCID:
PMC9937737.
Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning?.
Clin J Am Soc Nephrol.
2023 Apr 1;18(4):427-429. doi: 10.2215/CJN.0000000000000129. PubMed PMID:
37026748; PubMed Central PMCID:
PMC10103203.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA.
2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257. PubMed PMID:
36525245; PubMed Central PMCID:
PMC9857594.
Therapeutic advances in COVID-19.
Nat Rev Nephrol.
2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17. Review. PubMed PMID:
36253508; PubMed Central PMCID:
PMC9574806.
Target Trial Emulation: A Framework for Causal Inference From Observational Data.
JAMA.
2022 Dec 27;328(24):2446-2447. doi: 10.1001/jama.2022.21383. PubMed PMID:
36508210.
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.
Nat Rev Nephrol.
2022 Dec;18(12):794-805. doi: 10.1038/s41581-022-00630-8. Epub 2022 Sep 27. Review. PubMed PMID:
36168055.
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
Circ Cardiovasc Qual Outcomes.
2022 Oct;15(10):e008942. doi: 10.1161/CIRCOUTCOMES.122.008942. Epub 2022 Oct 4. PubMed PMID:
36193749; PubMed Central PMCID:
PMC9575399.
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney Int.
2022 Oct;102(4):930-935. doi: 10.1016/j.kint.2022.07.019. Epub 2022 Aug 11. PubMed PMID:
35964800; PubMed Central PMCID:
PMC9523226.
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
J Immunother Cancer.
2022 Sep;10(9). doi: 10.1136/jitc-2022-005646. PubMed PMID:
36137651; PubMed Central PMCID:
PMC9511654.
Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19.
Crit Care Explor.
2022 Sep;4(9):e0755. doi: 10.1097/CCE.0000000000000755. eCollection 2022 Sep. PubMed PMID:
36050992; PubMed Central PMCID:
PMC9426819.
Hispanic ethnicity and mortality among critically ill patients with COVID-19.
PLoS One.
2022;17(5):e0268022. doi: 10.1371/journal.pone.0268022. eCollection 2022. PubMed PMID:
35584148; PubMed Central PMCID:
PMC9116663.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA.
2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910. PubMed PMID:
35315874; PubMed Central PMCID:
PMC8941448.
Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19.
J Intensive Care Med.
2022 Apr;37(4):500-509. doi: 10.1177/08850666211067509. Epub 2021 Dec 23. PubMed PMID:
34939474; PubMed Central PMCID:
PMC8926920.
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.
Am J Kidney Dis.
2022 Mar;79(3):404-416.e1. doi: 10.1053/j.ajkd.2021.11.004. Epub 2021 Dec 4. PubMed PMID:
34871701; PubMed Central PMCID:
PMC8641974.
Controlled Study of Decision-Making Algorithms for Kidney Replacement Therapy Initiation in Acute Kidney Injury.
Clin J Am Soc Nephrol.
2022 Feb;17(2):194-204. doi: 10.2215/CJN.02060221. Epub 2021 Dec 15. PubMed PMID:
34911731; PubMed Central PMCID:
PMC8823944.
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors.
Am J Kidney Dis.
2022 Jan;79(1):134-137. doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24. PubMed PMID:
34174363; PubMed Central PMCID:
PMC8855486.
Protocol to assess performance of crisis standards of care guidelines for clinical triage.
STAR Protoc.
2021 Dec 17;2(4):100943. doi: 10.1016/j.xpro.2021.100943. Epub 2021 Nov 10. PubMed PMID:
34786562; PubMed Central PMCID:
PMC8580414.
Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19.
Medicine (Baltimore).
2021 Dec 17;100(50):e28302. doi: 10.1097/MD.0000000000028302. PubMed PMID:
34918709; PubMed Central PMCID:
PMC8677989.
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA.
2021 Nov 2;326(17):1690-1702. doi: 10.1001/jama.2021.18178. PubMed PMID:
34606578; PubMed Central PMCID:
PMC8491132.
Tissue Plasminogen Activator in Critically Ill Adults with COVID-19.
Ann Am Thorac Soc.
2021 Nov;18(11):1917-1921. doi: 10.1513/AnnalsATS.202102-127RL. PubMed PMID:
33872546; PubMed Central PMCID:
PMC8641829.
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors.
Eur J Cancer.
2021 Nov;157:50-58. doi: 10.1016/j.ejca.2021.07.031. Epub 2021 Sep 2. PubMed PMID:
34482189.
Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine.
Transfusion.
2021 Nov;61(11):3267-3271. doi: 10.1111/trf.16672. Epub 2021 Oct 3. PubMed PMID:
34549821; PubMed Central PMCID:
PMC8661722.
Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US.
Obesity (Silver Spring).
2021 Oct;29(10):1719-1730. doi: 10.1002/oby.23245. Epub 2021 Aug 6. PubMed PMID:
34109768.
Acute kidney injury in patients treated with immune checkpoint inhibitors.
J Immunother Cancer.
2021 Oct;9(10). doi: 10.1136/jitc-2021-003467. PubMed PMID:
34625513; PubMed Central PMCID:
PMC8496384.
Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States.
Cell Rep Med.
2021 Sep 21;2(9):100376. doi: 10.1016/j.xcrm.2021.100376. Epub 2021 Jul 28. PubMed PMID:
34337554; PubMed Central PMCID:
PMC8316067.
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.
Chest.
2021 Sep;160(3):929-943. doi: 10.1016/j.chest.2021.04.062. Epub 2021 May 6. PubMed PMID:
33964301; PubMed Central PMCID:
PMC8099539.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med.
2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. PubMed PMID:
34351722; PubMed Central PMCID:
PMC8362592.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med.
2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. PubMed PMID:
34351721; PubMed Central PMCID:
PMC8362594.
Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019.
Crit Care Explor.
2021 Aug;3(8):e0515. doi: 10.1097/CCE.0000000000000515. eCollection 2021 Aug. PubMed PMID:
34476402; PubMed Central PMCID:
PMC8378790.
Hospital-Level Variation in Death for Critically Ill Patients with COVID-19.
Am J Respir Crit Care Med.
2021 Aug 15;204(403-411):403-11. doi: 10.1164/rccm.202012-4547OC. PubMed PMID:
33891529; PubMed Central PMCID:
PMC8480242.
Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019.
Crit Care Med.
2021 Aug 1;49(8):e795-e796. doi: 10.1097/CCM.0000000000004999. PubMed PMID:
33779583; PubMed Central PMCID:
PMC8277043.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Intensive Care Med.
2021 Aug;47(8):867-886. doi: 10.1007/s00134-021-06448-5. Epub 2021 Jul 12. PubMed PMID:
34251506; PubMed Central PMCID:
PMC8274471.
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Kidney Int.
2021 Jul;100(1):196-205. doi: 10.1016/j.kint.2020.12.015. Epub 2020 Dec 24. PubMed PMID:
33359528; PubMed Central PMCID:
PMC8222056.
Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure.
Crit Care Med.
2021 Jul 1;49(7):1026-1037. doi: 10.1097/CCM.0000000000004938. PubMed PMID:
33595960; PubMed Central PMCID:
PMC8277560.
Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel.
Am J Kidney Dis.
2021 Jun;77(6):990-992. doi: 10.1053/j.ajkd.2020.08.017. Epub 2020 Oct 22. PubMed PMID:
33098925; PubMed Central PMCID:
PMC8060348.
A Systematic Review of the Incidence and Outcomes of In-Hospital Cardiac Arrests in Patients With Coronavirus Disease 2019.
Crit Care Med.
2021 Jun 1;49(6):901-911. doi: 10.1097/CCM.0000000000004950. PubMed PMID:
33710030.
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
Kidney Int.
2021 Jun;99(6):1280-1295. doi: 10.1016/j.kint.2021.03.020. Epub 2021 Apr 8. PubMed PMID:
33839163.
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
Ann Intern Med.
2021 May;174(5):622-632. doi: 10.7326/M20-6739. Epub 2021 Jan 26. PubMed PMID:
33493012; PubMed Central PMCID:
PMC7863679.
d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.
Crit Care Med.
2021 May 1;49(5):e500-e511. doi: 10.1097/CCM.0000000000004917. PubMed PMID:
33591017; PubMed Central PMCID:
PMC8275993.
Tocilizumab in COVID-19: some clarity amid controversy.
Lancet.
2021 May 1;397(10285):1599-1601. doi: 10.1016/S0140-6736(21)00712-1. PubMed PMID:
33933194; PubMed Central PMCID:
PMC8084409.
Hypoxia ameliorates brain hyperoxia and NAD(+) deficiency in a murine model of Leigh syndrome.
Mol Genet Metab.
2021 May;133(1):83-93. doi: 10.1016/j.ymgme.2021.03.005. Epub 2021 Mar 11. PubMed PMID:
33752971; PubMed Central PMCID:
PMC8489256.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med.
2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25. PubMed PMID:
33631065; PubMed Central PMCID:
PMC7953461.
Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
J Thorac Cardiovasc Surg.
2021 Apr;161(4):1510-1518. doi: 10.1016/j.jtcvs.2020.05.033. Epub 2020 May 29. PubMed PMID:
32631662.
What would you like to do?